Entacapone Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Entacapone Entacapone Amide Impurity VL2400006View CAS 158693-01-7
Entacapone Entacapone EP Impurity A VL2400007View CAS 145195-63-7
Entacapone Entacapone EP Impurity B VL2400014View CAS 857629-79-9
Entacapone Entacapone EP Impurity C VL2400003View CAS 116313-85-0
Entacapone Entacapone EP Impurity D VL2400008View
Entacapone Entacapone EP Impurity E VL2400004View CAS 7659-29-2
Entacapone Entacapone EP Impurity F VL2400010View CAS 160391-70-8
Entacapone Entacapone EP Impurity G VL2400005View CAS 1364322-41-7
Entacapone Entacapone EP Impurity H VL2400001View CAS 1150310-15-8
Entacapone Entacapone EP Impurity I VL2400009View CAS 1364322-42-8
Entacapone Entacapone Impurity 4 VL2400012View CAS 1202160-40-4
Entacapone Entacapone Methoxy (E/Z)-Mixture VE009764View CAS 146698-91-1
Entacapone Entacapone Methoxy Impurity VL2400013View CAS 857629-78-8
Entacapone Entacapone N N Diethyl Cyanoacetamide VL2400011View

Request a quote

1150310-15-8: Entacapone EP Impurity H

1150310-15-8: Entacapone EP Impurity H
Catalogue No.

VL2400001
CAS No.

1150310-15-8
Molecular Formula

C₁₅H₁₅N₃O₅
Molecular Weight

317.3
Parent drug

Entacapone
IUPAC Name

(αE)-α-[(3, 4-Dihydroxy-5-nitrophenyl)methylene]-β-oxo-1-piperidinepropanenitrile
Synonyms

Entacapone Inhouse Impurity C
References

"Schrag, Anette. Entacapone in the Treatment of Parkinson’s Disease.” The Lancet Neurology, vol. 4, no. 6, June 2005, pp. 366–70, https://doi.org/10.1016/s1474-4422(05)70098-3. ?Holm, Kristin J., and Caroline M. Spencer. Entacapone.” Drugs, vol. 58, no. 1, 1999, pp. 159–77, https://doi.org/10.2165/00003495-199958010-00017. ?"
Status

In-stock
ListName

Entacapone EP Impurity H
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url